Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 1988;12(4):313–323. doi: 10.1007/BF00343250

Increased plasma levels of leukotriene B4 and prostaglandin E2 in cats experimentally inoculated with feline infectious peritonitis virus

R C Weiss 1,2, D M Vaughn 1,3, N R Cox 1,2
PMCID: PMC7088611  PMID: 2848354

Abstract

Specific-pathogen-free kittens experimentally infected with feline infectious peritonitis virus (FIPV) subsequently demonstrated increased plasma levels of the arachidonic acid metabolites, leukotriene (LT) B4 and prostaglandin (PG) E2. Significant increases (P<0.025) in LTB4 plasma levels occurred in all (5/5) FIPV-inoculated kittens on postchallenge-exposure days (PCD) 7 and 14 vs PCD 0. Significant increases (P<0.05) in PGE2 plasma levels occurred in 80% (4/5) of FIPV-infected kittens on PCD 7 and 14. Maximal mean plasma levels of LTB4 and PGE2 occurred on PCD 7 (502.5±45.6 pg/ml and 1108.0±247.9 pg/ml, respectively). A positive correlation was found between LTB4 plasma levels and body temperature (r=0.609, P<0.01). Mean survival time in FIPV-inoculated kittens was 19.4±3.2 days. Gross lesions, including peritoneal or pleural effusions (or both) and connective tissue edema, indicated an increased vascular permeability in the FIPV-infected kittens. Histologically, lesions were characterized by pyogranulomatous inflammation. Immunofluorescent studies of tissues from FIPV-infected kittens demonstrated foci of polymorphonuclear leukocytes and FIPV-positive macrophages oriented around dilated blood vessels. Seemingly, arachidonic acid metabolites, including LTB4 or PGE2 released from macrophages, neutrophils or other cells, may be involved in the pathogenesis of FIP vascular and inflammatory lesions and in some of the clinical disease manifestations.

Keywords: Plasma Level, Prostaglandin, Arachidonic Acid, PGE2, Pleural Effusion

References

  1. August J. R. Feline infectious peritonitis: An immune-mediated coronaviral vaculitis. Vet. Clin. North Am. (Small Anim. Pract.) 1984;14:971–984. doi: 10.1016/S0195-5616(84)50102-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barlough J. E., Weiss R. C. Feline infectious peritonitis. In: Kirk R. W., editor. Current veterinary therapy VIII: Small animal practice. Philadelphia: W. B. Saunders Co; 1983. pp. 1186–1193. [Google Scholar]
  3. Cebula T. A., Hanson D. A., Moore D. M., et al. Synthesis of four endogenous pyrogens by rabbit macrophages. J. Lab. Clin. Med. 1979;94:95–105. [PubMed] [Google Scholar]
  4. Colten H. R. Biosynthesis of complement. Adv Immunol. 1976;22:67–118. doi: 10.1016/s0065-2776(08)60548-9. [DOI] [PubMed] [Google Scholar]
  5. Gerrard J. M. Prostaglandins and leukotrienes: Blood and vascular cell function. New York: Marcel Dekker Inc.; 1985. pp. 3–59. [Google Scholar]
  6. Gerrard J. M. Prostaglandins and leukotrienes: Blood and vascular cell function. New York: Marcel Dekker Inc; 1985. pp. 77–207. [Google Scholar]
  7. Gerrard J. M. Prostaglandins and leukotrienes: Blood and vascular cell function. New York: Marcel Dekker Inc; 1985. pp. 239–256. [Google Scholar]
  8. Goitsuka R., Hirota Y., Tomoda I. Release of interleukin-1 from peritoneal exudate cells of cats with feline infectious peritonitis. Jpn. J. Vet. Sci. 1987;49:811–818. doi: 10.1292/jvms1939.49.811. [DOI] [PubMed] [Google Scholar]
  9. Gordon A. H. Responses of connective and other tissue and cell types to injury-derived factors. In: Gordon A. H., Koj A., editors. The acute-phase response to injury and infection. Amsterdam: Elsevier Press; 1985. pp. 111–119. [Google Scholar]
  10. Holmberg C. A., Gribble D. H. Feline infectious peritonitis: Diagnostic gross and microscopic lesions. Feline Pract. 1973;4:11–14. [Google Scholar]
  11. Jacobse-Geels H. E. L., Daha M. R., Horzinek M. C. Isolation and characterization of feline C3 and evidence for the immune complex pathogenesis of feline infectious peritonitis. J. Immunol. 1980;125:1606–1610. [PubMed] [Google Scholar]
  12. Jacobse-Geels H. E. L., Daha M. R., Horzinek M. C. Antibody, immune complexes and complement activity. Fluctuations in kittens with experimentally induced feline infectious peritonitis. Am. J. Vet. Res. 1982;43:666–670. [PubMed] [Google Scholar]
  13. Koj A. Extrahepatic synthesis of acute-phase proteins. In: Gordon A. H., Koj A., editors. The acute-phase response to injury and injection. Amsterdam: Elsevier Press; 1985. pp. 221–226. [Google Scholar]
  14. Montali R. J., Strandberg J. D. Extraperitoneal lesions in feline infectious peritonitis. Vet. Pathol. 1972;9:109–121. doi: 10.1177/030098587200900204. [DOI] [PubMed] [Google Scholar]
  15. Parker C. W. Mediators: Release and function. In: Paul W. E., editor. Fundamental immunology. New York: Raven Press; 1984. pp. 697–747. [Google Scholar]
  16. Pedersen N. C., Boyle J. F. Immunologic phenomena in the effusive form of feline infectious peritonitis. Am. J. Vet. Res. 1980;41:868–876. [PubMed] [Google Scholar]
  17. Pedersen N. C. Feline infectious peritonitis and feline enteric coronavirus infections. Part 2: Feline infectious peritonitis. Feline Pract. 1983;13:5–20. [Google Scholar]
  18. Pedersen N. C., Black J. W. Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus. Am. J. Vet. Res. 1983;44:229–234. [PubMed] [Google Scholar]
  19. Pedersen N. C. Feline infectious peritonitis. In: Olsen R. G., Krakowka S., Blakeslee J. R., editors. Comparative pathobiology of viral diseases. Vol 2. Boca Raton: CRC Press Inc; 1985. pp. 115–136. [Google Scholar]
  20. Piper P. J. Formation and actions of leukotrienes. Physiol. Rev. 1984;64:744–761. doi: 10.1152/physrev.1984.64.2.744. [DOI] [PubMed] [Google Scholar]
  21. Rocklin R. E., Bendtzen K., Greineder D. Mediators of immunity: Lymphokines and monokines. Adv. Immunol. 1980;29:55–136. doi: 10.1016/s0065-2776(08)60043-7. [DOI] [PubMed] [Google Scholar]
  22. Slausen D. O., Finn J. P. Meningo-encephalitis and panophthalmitis in feline infectious peritonitis. J. Am. Vet. Med. Assoc. 1972;160:729–734. [PubMed] [Google Scholar]
  23. Stewart W. E. The interferon system. Wien: Springer Verlag; 1981. pp. 115–116. [Google Scholar]
  24. Stitt J. T. Prostaglandin E as the neural mediator of the febrile response. Yale J. Bio. Med. 1986;59:137–149. [PMC free article] [PubMed] [Google Scholar]
  25. Stringfellow D. A., Brideau R. Interferons and prostaglandins. In: Vilcek J., De Mayer E., editors. Interferon 2: Interferons and the immune system. Amsterdam: Elsevier Press; 1984. pp. 147–163. [Google Scholar]
  26. Weiss R. C., Scott F. W. Pathogenesis of feline infectious peritonitis: Nature and development of viremia. Am. J. Vet. Res. 1981;42:382–390. [PubMed] [Google Scholar]
  27. Weiss R. C., Scott F. W. Pathogenesis of feline infectious peritonitis: Pathologic changes and immunofluorescence. Am. J. Vet. Res. 1981;42:2036–2048. [PubMed] [Google Scholar]
  28. Weiss R. C., Scott F. W. Antibody-mediated enhancement of disease in feline infectious peritonitis: Comparisons with dengue hemorrhagic fever. Comp. Immun. Microbiol. Infect. Dis. 1981;4:175–189. doi: 10.1016/0147-9571(81)90003-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wolfe L. G., Griesemer R. A. Feline infectious peritonitis. Review of gross and histopathologic lesions. J. Am. Vet. Med. Assoc. 1971;158:987–993. [PubMed] [Google Scholar]
  30. Wolfe L. S., Coceani F. The role of prostaglandins in the central nervous system. Ann. Rev. Physiol. 1979;41:669–684. doi: 10.1146/annurev.ph.41.030179.003321. [DOI] [PubMed] [Google Scholar]

Articles from Veterinary Research Communications are provided here courtesy of Nature Publishing Group

RESOURCES